Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-25-039771
Filing Date
2025-04-28
Accepted
2025-04-28 07:07:52
Documents
1
Period of Report
2025-02-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2513284-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2513284-1_4aseq1.xml 4/A 4130
  Complete submission text file 0001104659-25-039771.txt   5685
Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Issuer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZENAS BIOPHARMA, INC. 1000 WINTER ST., SUITE 1200 WALTHAM MA 02451
Business Address
Xiao Ting (Reporting) CIK: 0002035283 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-42270 | Film No.: 25875928